BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Infinity Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:01 pm Sale | 2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ | BIOTECHNOLOGY VALUE FUND L P | 6,353,645 7.100% | -2,030,000 (-24.21%) | Filing |
| 2021-02-19 5:10 pm Unchanged | 2021-02-17 | 13G | Infinity Pharmaceuticals, Inc. INFIQ | BIOTECHNOLOGY VALUE FUND L P | 8,383,645 9.960% | 0 (Unchanged) | Filing |
| 2021-02-16 4:30 pm Sale | 2021-02-11 | 13D | Infinity Pharmaceuticals, Inc. INFIQ | BIOTECHNOLOGY VALUE FUND L P | 8,383,645 13.100% | -2,343,323 (-21.85%) | Filing |
| 2021-01-26 5:26 pm Sale | 2021-01-22 | 13D | Infinity Pharmaceuticals, Inc. INFIQ | BIOTECHNOLOGY VALUE FUND L P | 10,726,968 16.700% | -6,700,000 (-38.45%) | Filing |
| 2020-11-12 5:13 pm Unchanged | 2020-11-09 | 13D | Infinity Pharmaceuticals, Inc. INFIQ | BIOTECHNOLOGY VALUE FUND L P | 17,426,968 27.100% | 0 (Unchanged) | Filing |